In a move blending personal passion with tech innovation, Zomato's founder and CEO Deepinder Goyal has officially announced the impending launch of 'Temple', a mysterious wearable device recently spotted on his right temple. Goyal revealed that this experimental monitor, which he describes as "world class," is the first hardware outcome of his deep dive into unconventional longevity research.
What is the 'Temple' Device?
Temple is an experimental wearable designed to calculate Brain Flow accurately, in real-time, and continuously. Goyal clarified the device's purpose last month on LinkedIn, ending widespread speculation about the tiny gadget seen on his person. He explained that the necessity for such a monitor arose directly from his ongoing research into what he calls the "Gravity Aging Hypothesis."
Goyal has been personally using a prototype of the Temple device for about a year. His experience led him to believe this could evolve into a significant wearable that the world needs. He emphasised that Brain Flow is already a well-accepted biomarker for aging, longevity, and cognition. Therefore, the device maintains its relevance and utility even if his underlying hypothesis about gravity is proven incorrect.
The Science Behind the Device: The Gravity Aging Hypothesis
The development of Temple is intrinsically linked to Goyal's publicly shared and unconventional scientific theory. The Gravity Aging Hypothesis proposes that gravity may contribute to human aging by potentially reducing blood flow to the brain over a lifetime. "Newton gave us a word for it. Einstein said it bends spacetime. I am saying gravity shortens lifespan," Goyal wrote while introducing the idea.
He later acknowledged miscommunicating the complex hypothesis in his initial social media reveal, apologising for making it sound "absolute and commercial." He has since committed to taking a slower, cleaner approach to explaining the Gravity Aging Hypothesis without oversimplifying years of research.
Not a Marketing Gimmick, But a Passion Project
In his announcements, Deepinder Goyal was keen to distinguish this venture from his role at Zomato or its subsidiary, Eternal. He stated he is sharing this "as a fellow human, curious enough to follow a strange thread." He assured that the Gravity Aging Hypothesis was not "cooked up" to sell the Temple device, stressing that losing customer trust over a marketing stunt is "not my game."
Goyal clarified that Temple is intended to be a "small cute company," separate and nothing compared to the scale of Eternal. His post simply ended with a teaser: "Coming Soon. Follow @temple for more updates," and in a reply to a comment, he confidently labelled the device "World class, to say the least."
This announcement marks a fascinating foray of a prominent Indian tech entrepreneur into the frontier of bio-wearables and longevity science, promising a new tool to monitor a key biomarker directly from one's temple.
